OraSure Technologies

OraSure Technologies Current Assets

The Current Assets of OraSure Technologies (OSUR) as of Oct 23, 2026 is 239.70 M USD. In the previous year, Current Assets was 333.22 M USD — a change of -28.06% (lower).

Current Assets

239.70 MUSD

YoY

-28.06%

Last updated:

Current Assets of OraSure Technologies is 2025 239.70 M USD. Current Assets of OraSure Technologies was 2024 333.22 M USD. It decreases by -28.06% lower compared to the previous year.

The OraSure Technologies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
219.27 M USD
Jan 1, 2019
224.50 M USD
Jan 1, 2020
288.86 M USD
Jan 1, 2021
299.28 M USD
Jan 1, 2022
325.19 M USD
Jan 1, 2023
386.46 M USD
Jan 1, 2024
333.22 M USD
Jan 1, 2025
239.70 M USD
The OraSure Technologies Current Assets history
YEARCurrent AssetsYoY
239.70 MUSD-28.06%
333.22 MUSD-13.78%
386.46 MUSD+18.84%
325.19 MUSD+8.66%
299.28 MUSD+3.61%
288.86 MUSD+28.67%
224.50 MUSD+2.39%
219.27 MUSD-1.99%
223.72 MUSD+41.38%
158.25 MUSD+15.72%
136.75 MUSD+4.25%
131.18 MUSD+9.66%
119.62 MUSD-0.61%
120.36 MUSD+127.62%
52.88 MUSD-100.73%
-7.24 BUSD-7,007.49%
104.82 MUSD-1.34%
106.24 MUSD-14.17%
123.79 MUSD+9.94%
112.60 MUSD+11.04%
101.41 MUSD+26.80%
79.97 MUSD+3.66%
77.15 MUSD+207.10%
25.12 MUSD-6.17%
26.77 MUSD-5.18%
28.24 MUSD+149.89%
11.30 MUSD+61.43%
7.00 MUSD-33.33%
10.50 MUSD-59.77%
26.10 MUSD+7.41%
24.30 MUSD+28.57%
18.90 MUSD+92.86%
9.80 MUSD-2.97%
10.10 MUSD-12.17%
11.50 MUSD+173.81%
4.20 MUSD-23.64%
5.50 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OraSure Technologies Stock analysis

What does OraSure Technologies do? OraSure Technologies Inc. is a US company specializing in the development, manufacturing, and marketing of diagnostic medical products. It was founded in 1987 under the name SolarCare Technologies Corporation and changed its name to OraSure Technologies Inc. in 2000. The company's main goal is to reduce the prevalence of infectious diseases and improve global health. It focuses on four core areas: infectious diseases, microfluidic analysis, application management, and genomics. In the field of infectious diseases, OraSure Technologies Inc. produces various rapid tests for detecting diseases such as HIV, Hepatitis C, and Syphilis. It also offers tests for drug and alcohol consumption verification. In microfluidic analysis, the company produces devices and test kits for biomedical research and clinical use. These technologies allow for the quick analysis of small samples and accurate results. Application management is another important aspect of the company, offering cloud-based applications for optimized data and information management. These applications help businesses and institutions obtain real-time data and use data analytics tools. Additionally, OraSure Technologies Inc. is involved in genomics and offers various products and services related to DNA sequencing. The company has a broad customer base, ranging from government agencies and research institutions to service companies and private clinics. It operates in numerous countries worldwide. An example of a product from OraSure Technologies is the OraQuick HIV self-test, which allows individuals to determine within 20 minutes whether they are infected with the HIV virus or not. This is particularly important for people who cannot or do not want to visit a doctor and value their privacy. OraSure Technologies' history is marked by numerous innovations and significant milestones. One notable event was the development of the first oral HIV rapid test in 2004, which allowed for quick and reliable detection of the virus through a saliva sample instead of a blood sample. In recent years, the company has increased its investment in research and development and formed partnerships with companies and institutions to bring innovative diagnostic medical products to the market. In summary, OraSure Technologies Inc. is a leading US company specializing in the development, manufacturing, and marketing of diagnostic medical products. With a focus on infectious diseases, microfluidic analysis, application management, and genomics, the company has a wide range of products and a broad customer base. OraSure Technologies is an innovative company striving to improve global health through partnerships and investments in research and development. OraSure Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OraSure Technologies stock

Current Assets of OraSure Technologies is 239.70 M USD in 2025.

Current Assets of OraSure Technologies changed from 333.22 M USD to 239.70 M USD, representing a -28.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets OraSure Technologies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's OraSure Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — OraSure Technologies

All Key Metrics — OraSure Technologies